Oncology refers to a field of medical science that deals with tumors and cancers. The word onco means mass, volume or tumor while logy means study. A doctor who treats oncology is called an oncologist. Usually, an oncologist handles care and treatment once a person is diagnosed with cancer. Say no to plagiarism. Get a tailor-made essay on “Why Violent Video Games Should Not Be Banned”? Get the original essay Cancer is an abnormal cell growth with the possibility of spreading or invading other parts of the body as well. Not all tumors are cancerous, and benign tumors do not spread to other parts of the body. Cancer also called malignant tumor or malignant tumor. The lecture series organizes many cancer lectures on different types of cancers such as breast cancer, leukemia, oral cancer, skin cancer, lung cancer, colon cancer, cancer rectal, prostate cancer, cervical cancer, melanoma and carcinoma. Symptoms may vary depending on the type. Cancer treatment may include chemotherapy, radiotherapy and/or surgery. Now daily vaccines were also available for specific cancers. Many conferences on oncology and cancer are organized by Conference Series. 3000+ global conferences with 600+ lectures, 1200+ symposia and 1200+ workshops on medicine, pharmacy, engineering, science, technology and business in different parts of the world including the United States, Canada, Europe, United Kingdom, Middle East and United Arab Emirates. and other regions of Asia-Pacific. Young Investigator Forum, Best Poster Award, E-Poster, Live Streaming, B2B Meetings, Exhibition and Sponsorship Opportunities are other important features of these Cancer Meetings. Oncology Conferences and Cancer Meetings provide an excellent opportunity for budding scientists and young researchers through their special program. initiatives such as the Young Researchers Forum, poster presentation, e-posters and live streaming, B2B and scientific meetings. B2B meetings are a quick and easy way to meet potential cooperation partners. It is estimated that approximately 12.7 million cancer cases and 7.6 million cancer deaths occurred in 2008 worldwide, with 56% of cases and 64% of deaths in economically developing countries. . Breast cancer, the most common tumor in women, has a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignancy survive more than five years. Colorectal cancer (colon and rectum), the most common malignant tumor. if we group men and women together, it has an average survival rate of 50 to 55% five years after diagnosis, which means that half of patients survive this form of cancer. Prostate cancer, today the most common tumor in men, has an increasingly favorable prognosis, with an overall survival rate of 76%, higher in young adults. Ovarian cancer has a very varied prognosis depending on age: while 70% of people aged 15 to 44 survive this form of cancer, this is the case for only 19% of people over 74. . Global profiling of cancers/tumors The market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated at $14.99 billion and is expectedreach approximately $35 billion by 2018, with a CAGR of 18.50% from 2013 to 2018. Global spending on oncology was hit $91 billion for 2013 and this figure is growing at the rate of 5% per year, to reach $100 billion in 2015. The major players in the cancer and tumor profiling market are Boreal Genomics Inc. (US), Caris Life Sciences (US), Genomic Health. Inc. (United States), Illumina Inc. (United States), Life Technologies Corporation (United States), NeoGenomics Laboratories (United States), Oxford Gene Technology Ltd. (UK), Precision Therapeutics Inc. (US), bioTheranostics (US), Proteome Sciences PLC (UK), Agendia (Netherlands), Nanostring Technologies (US), Rational Therapeutics ( United States), Oncopath Laboratories (United States) and RiboMed Biotechnologies Inc. (WE). The global cancer diagnostics market is expected to reach $13.1 billion in 2020, up from an estimated $7.1 billion in 2015, with a CAGR of 12.9%. The market is dominated by North America, followed by Europe, Asia and the Rest of the World (RoW). The cancer diagnostics market in Asia is expected to witness the fastest growth between 2015 and 2020. According to the market, the global oncology drugs market is expected to reach $111.9 billion by 2020. Expiry of drug patents key anticancer drugs such as Herceptin, Erbitux, Rituxan and Avastin are expected to drive the growth of the anticancer biosimilars market by 2020. Conference Series LLC has designed global platforms to interact and collaborate with speakers, experts and industry professionals renowned at its 3,000+ global events with 600+ conferences, 1,200+ symposia and 1,200+ workshops on various medical, pharmaceutical, engineering, scientific, technological and business fields. Oncology and cancer conferences hosted by Conference Series LLC focus on all types of common and rare cancers, as well as various diagnostic and treatment modalities. Cancer is the name given to a group of related diseases, a class of diseases characterized by uncontrolled illness. cell growth. In all types of cancer, some cells in the body begin to divide nonstop and spread into surrounding tissues. Cancer is a disease in which cells in a specific part of the body grow and reproduce uncontrollably. Cancer sometimes starts in one part of the body before spreading to other areas. This process is known as metastasis. Causes and presentation are the other major aspects of cancer research. There are few common causes, while unique, organ-specific causes of cancer have also been found. Research is significant and promising in the area of ​​organ-specific research to better understand organ-specific cancer and implement personalized treatment options. The study of cancer and tumors is known as oncology. The term oncology can be literally divided into two parts: "onco" means mass, lump or tumor, while "-logy" means study. A doctor who specializes in treating people with cancer is called an oncologist. Usually, an oncologist manages care and treatment once a person is diagnosed with cancer. Scope and importance. Cancer is considered one of the leading causes of morbidity and mortality worldwide. It is a complex health problem that requires a multidisciplinary approach. This approach is wide-ranging and extends from health promotion to prevention and screening, diagnosis,..